Funding opportunities for rare pancreatic diseases.

摘要

Historically, one of the most difficult roadblocks toward obtaining funding for the study of pancreatic diseases is the relatively low incidence of several of them, thereby identifying them as 'rare diseases'. In fact, many pharmaceutical companies do not want to invest even in our more common pancreatic diseases, such as chronic pancreatitis and pancreatic cancer. Additional rare diseases which remain 'funding orphans' include certain cancers such as acinar carcinoma, autoimmune pancreatitis, and various types of diseases characterized by cysts, both benign and malignant, among others. For these reasons, we provide the following websites that deal with funding sources to hopefully serve as a useful place to request funding for rare pancreatic diseases. and IAP.